Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.
Open Access
- 1 February 1993
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 56 (2), 204-206
- https://doi.org/10.1136/jnnp.56.2.204
Abstract
A recent report described serum anti-GQ1b ganglioside antibodies in Miller Fisher syndrome (MFS), a clinical variant of Guillain-Barré syndrome (GBS). Four consecutive cases of MFS all had high titre anti-GQ1b antibodies which were absent from all control sera including those of patients with GBS.This publication has 7 references indexed in Scilit:
- Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndromeAnnals of Neurology, 1992
- Acute motor neuropathy with antibodies to GM1 gangliosideZeitschrift für Neurologie, 1991
- Acute axonal polyneuropathy associated with anti‐GM 1 antibodies following Campylobacter enteritisNeurology, 1990
- Serum antibodies to gangliosides in guillain‐barré syndromeAnnals of Neurology, 1988
- Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous systemChemistry and Physics of Lipids, 1986
- Gangliosides of peripheral nerve myelin.1976
- An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)The New England Journal of Medicine, 1956